| Potent neutralizing antibodies from COVID-19 patients define multiple targets of vulnerability PJM Brouwer, TG Caniels, K van der Straten, JL Snitselaar, Y Aldon, ... Science 369 (6504), 643-650, 2020 | 1185 | 2020 |
| Defining variant-resistant epitopes targeted by SARS-CoV-2 antibodies: A global consortium study KM Hastie, H Li, D Bedinger, SL Schendel, SM Dennison, K Li, ... Science 374 (6566), 472-478, 2021 | 269 | 2021 |
| The effect of spike mutations on SARS-CoV-2 neutralization C Rees-Spear, L Muir, SA Griffith, J Heaney, Y Aldon, JL Snitselaar, ... Cell reports 34 (12), 2021 | 246 | 2021 |
| The effect of spike mutations on SARS-CoV-2 neutralization C Rees-Spear, L Muir, SA Griffith, J Heaney, Y Aldon, JL Snitselaar, ... Cell reports 34 (12), 2021 | 246 | 2021 |
| Inside out: optimization of lipid nanoparticle formulations for exterior complexation and in vivo delivery of saRNA AK Blakney, PF McKay, BI Yus, Y Aldon, RJ Shattock Gene therapy 26 (9), 363-372, 2019 | 176 | 2019 |
| Two-component spike nanoparticle vaccine protects macaques from SARS-CoV-2 infection PJM Brouwer, M Brinkkemper, P Maisonnasse, N Dereuddre-Bosquet, ... Cell 184 (5), 1188-1200. e19, 2021 | 159 | 2021 |
| Rational design of DNA-expressed stabilized native-like HIV-1 envelope trimers Y Aldon, PF McKay, J Allen, G Ozorowski, RF Lévai, M Tolazzi, P Rogers, ... Cell reports 24 (12), 3324-3338. e5, 2018 | 59 | 2018 |
| COVA1-18 neutralizing antibody protects against SARS-CoV-2 in three preclinical models P Maisonnasse, Y Aldon, A Marc, R Marlin, N Dereuddre-Bosquet, ... Nature communications 12 (1), 1-10, 2021 | 46 | 2021 |
| Enhancing glycan occupancy of soluble HIV-1 envelope trimers to mimic the native viral spike R Derking, JD Allen, CA Cottrell, K Sliepen, GE Seabright, WH Lee, ... Cell Reports 35 (1), 108933, 2021 | 41 | 2021 |
| Effects of cationic adjuvant formulation particle type, fluidity and immunomodulators on delivery and immunogenicity of saRNA AK Blakney, PF McKay, D Christensen, BI Yus, Y Aldon, F Follmann, ... Journal of Controlled Release 304, 65-74, 2019 | 40 | 2019 |
| Identification of potential biomarkers of vaccine inflammation in mice PF McKay, D Cizmeci, Y Aldon, J Maertzdorf, J Weiner, SHE Kaufmann, ... Elife 8, e46149, 2019 | 37 | 2019 |
| A public antibody class recognizes an S2 epitope exposed on open conformations of SARS-CoV-2 spike M Claireaux, TG Caniels, M de Gast, J Han, D Guerra, G Kerster, ... Nature Communications 13 (1), 4539, 2022 | 34 | 2022 |
| Intravaginal immunisation using a novel antigen-releasing ring device elicits robust vaccine antigen-specific systemic and mucosal humoral immune responses PF McKay, JFS Mann, A Pattani, V Kett, Y Aldon, D King, RK Malcolm, ... Journal of Controlled Release 249, 74-83, 2017 | 28 | 2017 |
| Probing Affinity, Avidity, Anticooperativity, and Competition in Antibody and Receptor Binding to the SARS-CoV-2 Spike by Single Particle Mass Analyses V Yin, SH Lai, TG Caniels, PJM Brouwer, M Brinkkemper, Y Aldon, H Liu, ... ACS central science 7 (11), 1863-1873, 2021 | 19 | 2021 |
| Immunogenicity of stabilized HIV-1 Env trimers delivered by self-amplifying mRNA Y Aldon, PF McKay, JM Herrero, AB Vogel, R Lévai, P Maisonnasse, ... Molecular Therapy-Nucleic Acids 25, 483-493, 2021 | 18 | 2021 |
| A phase 1 human immunodeficiency virus vaccine trial for cross-profiling the kinetics of serum and mucosal antibody responses to CN54gp140 modulated by two homologous prime … S Kratochvil, PF McKay, JT Kopycinski, C Bishop, PJ Hayes, L Muir, ... Frontiers in immunology 8, 595, 2017 | 17 | 2017 |
| Discrete partitioning of HIV-1 Env forms revealed by viral capture DJ Stieh, DF King, K Klein, Y Aldon, PF McKay, RJ Shattock Retrovirology 12 (1), 1-15, 2015 | 17 | 2015 |
| Germline-targeting HIV-1 Env vaccination induces VRC01-class antibodies with rare insertions TG Caniels, M Medina-Ramírez, J Zhang, A Sarkar, S Kumar, ... Cell Reports Medicine 4 (4), 2023 | 14 | 2023 |
| Chemokine-Adjuvanted Plasmid DNA Induces Homing of Antigen-Specific and Non–Antigen-Specific B and T Cells to the Intestinal and Genital Mucosae Y Aldon, S Kratochvil, RJ Shattock, PF McKay The Journal of Immunology 204 (4), 903-913, 2020 | 13 | 2020 |
| Fine-mapping the immunodominant antibody epitopes on consensus sequence-based HIV-1 envelope trimer vaccine candidates E Reiss, MM van Haaren, J van Schooten, MAF Claireaux, ... npj Vaccines 7 (1), 152, 2022 | 6 | 2022 |
